Selective Killing of Contaminating Human Fibroblasts in Epithelial Cultures Derived From Colorectal Tumours Using an Anti Thy-1 Antibody-Ricin Conjugate

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1985.19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antibody Inhibition of Human Cytomegalovirus Spread in Epithelial Cell Cultures

Journal of Virological Methods
Virology
2013English

Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumours

Nature
Multidisciplinary
2009English

Use of SM-1 Monoclonal Antibody and Human Complement in Selective Killing of Small Cell Carcinoma of the Lung.

Journal of Clinical Investigation
Medicine
1985English

Developing an Antibody-Drug Conjugate Approach to Selective Inhibition of an Extracellular Protein

ChemBioChem
Organic ChemistryBiochemistryMolecular MedicineMolecular Biology
2019English

Selective Chemotherapy for Cancers by Using Monoclonal Antibody to Colorectal Cancers as a Carrier Antibody Bound Anti-Tumor Drugs.

Drug Delivery System
Pharmaceutical Science
1988English

Human Gingival Fibroblasts Display a Non-Fibrotic Phenotype Distinct From Skin Fibroblasts in Three-Dimensional Cultures

PLoS ONE
Multidisciplinary
2014English

Establishment and Optimization of Epithelial Cell Cultures From Human Ectocervix, Transformation Zone, and Endocervix Optimization of Epithelial Cell Cultures

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Selective Cytotoxic Activity of Immunotoxins Composed of a Monoclonal Anti-Thy 1.1 Antibody and the Ribosome-Inactivating Proteins Bryodin and Momordin

British Journal of Cancer
Cancer ResearchOncology
1988English

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-Sn-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy